Table 2.
Comparison of those with (n = 294) and without (n = 679) HCV or HBV.
| Anti-HCV − | Anti HCV + | p-value | |
|---|---|---|---|
| Age (yrs)* | 40.8 ± .36 | 46.0 ± .61 | <.0001 |
| % male | 63 | 65 | NS |
| % white | 17 | 3 | .0007 |
| BMI | 27 ± .24 | 25 ± .41 | .027 |
| BMI > 30 (%) | 25 | 17 | .03 |
| DM (%) | 6 | 7 | NS |
| HTN (%) | 25 | 32 | NS |
| Dyslipidemia | 28 | 16 | .0005 |
| Metabolic Syn | 23 | 18 | NS |
| CD 4 count | 449 ± 12 | 456 ± 21 | NS |
| HIV RNA <400 | 41 | 36 | .03 |
| % CD 4 < 200 | 24 | 21 | NS |
| % ALT Elevated | 15 | 44 | <.0001 |
| % AST Elevated | 19 | 63 | <.0001 |
| % ALP Elevated | 43 | 61 | <.0001 |
| NTRI use (%) | 63 | 65 | NS |
| NNRTI use (%) | 28 | 25 | NS |
| PI use (%) | 36 | 41 | .052 |
mean ± standard error; NS = not significant
BMI = body mass index; DM = diabetes mellitus; HTN = hypertension; Syn = syndrome; NTRI; nucleoside reverse transcriptase inhibitor; NNRTI = non- nucleoside reverse transcriptase inhibitor; PI = protease inhibitor